ALVEOLAR RHABDOMYOSARCOMA
Clinical trials for ALVEOLAR RHABDOMYOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new ALVEOLAR RHABDOMYOSARCOMA trials appear
Sign up with your email to follow new studies for ALVEOLAR RHABDOMYOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could adding temsirolimus boost chemo for childhood muscle cancer?
Disease control OngoingThis phase 3 trial tests whether adding the drug temsirolimus to standard chemotherapy helps children and young adults with intermediate-risk rhabdomyosarcoma, a type of muscle cancer. About 325 participants receive either standard chemo or standard chemo plus temsirolimus. The s…
Matched conditions: ALVEOLAR RHABDOMYOSARCOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug cocktail shows promise against aggressive childhood cancer
Disease control OngoingThis study tests whether adding a drug called vinorelbine to standard chemotherapy can better control high-risk rhabdomyosarcoma, a rare and aggressive muscle cancer in children and young adults. About 118 participants will receive either the standard treatment or the new combina…
Matched conditions: ALVEOLAR RHABDOMYOSARCOMA
Phase: PHASE3 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Gene hunt: could DNA secrets unlock rhabdomyosarcoma prognosis?
Knowledge-focused OngoingThis study explores genetic mutations in children with embryonal or alveolar rhabdomyosarcoma by analyzing saliva or cheek cell samples from the child and their parents. The goal is to identify inherited or new gene changes that may help doctors predict how the disease will progr…
Matched conditions: ALVEOLAR RHABDOMYOSARCOMA
Sponsor: Children's Oncology Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC